Zenithpharma Listed by meow Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

People whose details sit inside a pharmaceutical company’s systems have a practical stake when that company appears on a ransomware leak site: internal files can hold names, contact data, health-related records, contracts or credentials that outsiders can misuse. On 5 November 2023, Zenithpharma was listed by the group known as meow, which claimed that internal files had been taken in a ransomware attack and that 15 percent had already been leaked. The number of people affected remains unknown, and public detail is limited, yet the listing alone is enough reason for anyone linked to the organisation to pay attention.

Inside the incident

According to the available record, Zenithpharma was publicly listed by the meow ransomware group on 5 November 2023. The group’s claim states that internal files were exfiltrated during a ransomware attack and that 15 percent of the material had been leaked. No further confirmed figures—such as the total volume of data, the precise date the intrusion began, the initial access method, or the number of individuals whose information is involved—have been disclosed in the public summary. Whether the organisation has verified the claim, negotiated with the group, or recovered systems is likewise unconfirmed. What is known is limited to the listing itself and the stated partial leak of internal files.

Inside meow

Meow is a ransomware actor that has appeared on public leak sites in recent years, typically posting victim names and asserting that data was stolen before encryption or destruction. Like other groups operating in this space, it relies on the threat of publication to pressure organisations. Public reporting on meow has described opportunistic targeting of exposed systems and the use of leak-site posts to advertise claimed exfiltration. In this case the group claims Zenithpharma’s internal files were taken and that 15 percent have been leaked; those assertions remain the group’s unverified statements rather than independently confirmed findings. No additional statements from meow specifically about Zenithpharma beyond the listing and the 15 percent figure are part of the public record used here.

Who is Zenithpharma?

Zenithpharma is an organisation operating in the pharmaceutical sector. Companies in this field ordinarily manage research data, manufacturing and supply-chain records, regulatory filings, employee information, and sometimes patient or clinical-trial related material. Even when a firm is not a household name, the sensitivity of the data it holds makes a claimed breach consequential: partners, staff and anyone whose information appears in internal files can face downstream risk if that material circulates. A listing on a ransomware leak site therefore raises immediate questions about what was stored, who might be identifiable within it, and how far any exfiltrated content has travelled.

What was likely exposed

The public facts name only “internal files exfiltrated in ransomware attack” and the group’s claim that 15 percent has been leaked. Exact data types, file counts and whether personal or health-related information is included are not disclosed. Organisations of this kind typically hold a range of material that could appear in internal files; the following are common categories, not confirmed contents of this incident:

• Employee and contractor records (names, contact details, identification or payroll data)
• Business correspondence, contracts and supplier information
• Research, manufacturing or regulatory documents
• Credentials, system configurations or other operational data

Because the precise contents remain unconfirmed, no one can yet state which of these, if any, were among the files the group claims to hold.

Why it matters

For individuals, the real-world risk is misuse of any personal or professional information that may have been inside those internal files—phishing that appears legitimate, identity fraud, or exposure of sensitive health or employment details. For the organisation, a claimed exfiltration and partial leak can disrupt operations, damage trust with partners and regulators, and create long-term monitoring obligations even if the full scope stays unclear. Because the number of people affected is unknown and the exact data types are undisclosed, the prudent stance is to treat the possibility of exposure seriously without assuming every record has been published. The 15 percent figure offered by the group is a claim, not an audited inventory; until more is verified, both the company and anyone connected to it are left working with incomplete information.

Were you affected?

If you have worked for, contracted with, or supplied Zenithpharma, or if you have other reason to believe your information sat in its systems, treat the listing as a prompt to act. Change passwords on related accounts, enable multi-factor authentication where available, and watch for unexpected messages that reference the company or your professional details. Monitor financial and credit statements for unfamiliar activity. You can also run a free exposure scan of your email address to check whether your information has already surfaced in known breach data. Public detail on this incident remains limited; staying alert to further verified notices from the organisation itself is the most reliable next step.

AICompiled with AI assistance from public sources and published under our editorial standards.